马雷辛1通过抑制NF-κB/Stat3/MAPK通路来预防败血症引起的急性肝损伤,减轻炎症

Shujun Sun1,2,3, Li Wang1,2,3, Jiamei Wang4

  • 1Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Heliyon
|November 29, 2023
PubMed
概括

马雷辛1 (MaR1) 在小鼠中有效治疗败血症引起的急性肝损伤 (SI-ALI). 这种omega-3衍生物减少炎症和细菌负载,改善生存率和肝功能.